TrialCirculation2013

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Ravi Sarode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.